JGC
PBYI icon

J. Goldman & Co’s Puma Biotechnology PBYI Stock Holding History

J. Goldman & Co’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-238,617
Closed -$2.45M – 535
2020
Q4 		$2.45M Buy
+238,617
New +$2.42M 0.19% 177
2018
Q1 		– Sell
-31,829
Closed -$3.15M – 440
2017
Q4 		$3.15M Buy
31,829
+15,429
+94% +$1.73M 0.29% 155
2017
Q3 		$1.96M Buy
+16,400
New +$1.53M 0.19% 196
2017
Q2 		– Sell
-3,102
Closed -$115K – 425
2017
Q1 		$115K Buy
+3,102
New +$113K 0.01% 308
2016
Q4 		– Sell
-49,500
Closed -$3.32M – 393
2016
Q3 		$3.32M Buy
+49,500
New +$2.5M 0.38% 148

Other funds holding PBYI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return